Table 1. MRI indication.
Targeted organ |
MRI indication |
No of patients |
|
normoglycemic |
Type 2 diabetic |
||
liver |
ear, nose and throat tumors |
2 |
0 |
melanoma |
2 |
0 |
|
small cell lung carcinoma |
1 |
0 |
|
non small cell lung carcinoma |
6 |
0 |
|
breast cancer |
7 |
0 |
|
hepatocellular carcinoma |
6 |
0 |
|
hepatic nodule |
0 |
2 |
|
hepatic abcess |
1 |
0 |
|
gallbladder carcinoma |
1 |
0 |
|
cholangiocarcinoma |
6 |
1 |
|
ampulloma |
2 |
0 |
|
esophagus tumor |
1 |
0 |
|
gastric adenocarcinoma |
4 |
0 |
|
gastrointestinal stromal tumor |
3 |
0 |
|
duodenal carcinoma |
1 |
0 |
|
terminal ileon carcinoid |
2 |
0 |
|
colorectal cancer |
45 |
14 |
|
pancreatic carcinoma |
4 |
2 |
|
retroperitoneal sarcoma |
1 |
0 |
|
nephroblastoma |
3 |
0 |
|
urothelial tumor |
3 |
1 |
|
ovarian cancer |
3 |
0 |
|
endometrial cancer |
1 |
0 |
|
testicular cancer |
1 |
0 |
|
diffuse non differentiated cancer |
0 |
1 |
|
diffuse neuroendocrine tumor |
1 |
0 |
|
multiple myeloma |
1 |
0 |
|
biliary tract |
fistules, leaks, post-traumatic and post-surgery indications |
10 |
2 |
pancreas |
carcinoma |
1 |
1 |
Total number of patients |
119 | 24 |